Intrinsic Value Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Sell
9,767
-130
-1% -$15.2K 0.86% 27
2026
Q1
$1.19M Sell
9,897
-370
-4% -$42.7K 0.92% 27
2025
Q4
$1.08M Sell
10,267
-2,918
-22% -$274K 0.81% 30
2025
Q3
$1.11M Sell
13,185
-2,060
-14% -$170K 0.9% 25
2025
Q2
$1.21M Sell
15,245
-432
-3% -$34.3K 1.07% 24
2025
Q1
$1.41M Buy
15,677
+12,928
+470% +$1.21M 1.39% 18
2024
Q4
$273K Hold
2,749
0.27% 56
2024
Q3
$312K Hold
2,749
0.31% 54
2024
Q2
$340K Sell
2,749
-40
-1% -$5.15K 0.35% 51
2024
Q1
$368K Sell
2,789
-1,450
-34% -$179K 0.39% 48
2023
Q4
$462K Sell
4,239
-88
-2% -$9.13K 0.54% 39
2023
Q3
$445K Sell
4,327
-20
-0.5% -$2.16K 0.57% 37
2023
Q2
$502K Hold
4,347
0.63% 38
2023
Q1
$462K Sell
4,347
-140
-3% -$15.1K 0.63% 38
2022
Q4
$498K Sell
4,487
-208
-4% -$21.3K 0.68% 36
2022
Q3
$404K Sell
4,695
-20
-0.4% -$1.78K 0.56% 40
2022
Q2
$430K Sell
4,715
-706
-13% -$62.6K 0.55% 38
2022
Q1
$445K Sell
5,421
-162
-3% -$12.8K 0.47% 35
2021
Q4
$428K Buy
+5,583
New +$445K 0.46% 35

Other funds holding MRK

Intrinsic Value Partners's MRK Position: Q2 2026 in Review

Intrinsic Value Partners reduced its Merck (MRK) stake by 1.3% in Q2 2026, selling an estimated $15.2K and leaving 9,767 shares worth $1.26M. The position accounts for 0.86% of the portfolio, ranked #27.

Intrinsic Value Partners first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.41M in Q1 2025. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Intrinsic Value Partners held 9,767 shares of Merck worth $1.26M as of Q2 2026.
  • Intrinsic Value Partners sold 130 Merck shares in Q2 2026, an estimated $15.2K.
  • Merck made up 0.86% of Intrinsic Value Partners's portfolio in Q2 2026, its #27 holding.
  • Intrinsic Value Partners first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Intrinsic Value Partners's Merck position peaked at $1.41M in Q1 2025.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Intrinsic Value Partners's 13F filing for Q2 2026, filed 14 Jul 2026.